Thompson David Blair’s Elevance Health ELV Stock Holding History

Thompson David Blair’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234K	Buy	+606	New	+$225K	0.12%	196

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Thompson David Blair's ELV Position: Q2 2026 in Review

Thompson David Blair opened a new position in Elevance Health (ELV) in Q2 2026: 606 shares worth $234K. The stake represents 0.12% of the portfolio and ranks #196 among its holdings.

1,513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Thompson David Blair held 606 shares of Elevance Health worth $234K as of Q2 2026.
Elevance Health was a new Thompson David Blair position in Q2 2026.
Elevance Health made up 0.12% of Thompson David Blair's portfolio in Q2 2026, its #196 holding.
1,513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Thompson David Blair's 13F filing for Q2 2026, filed 14 Aug 2026.